We have combined electrophysiology and chemical separation and measurement techniques with capillary electrophoresis (CE) 
Introduction
For the past decade and a half, there has been a shift in thinking associated with D-amino acids. Previously thought to be of little consequence in higher species, it has become clear that some D-amino acids are physiologically relevant in vertebrates. The most convincing case for a functional role of a D-amino acid is that of D-serine which is now thought to serve as an essential coagonist for NMDARs in many regions of the central nervous system. The unique activation properties of NMDARs require the simultaneous binding of glutamate together with a coagonist which binds at the 'glycine binding site.' Although it was originally assumed that glycine was the native coagonist for this essential function, recent studies suggest that in many regions of the nervous system D-serine may be the dominant endogenous coagonist (19; 26) . Dserine is synthesized in the nervous system from L-serine by the enzyme serine racemase which was initially localized to astrocytes (29) . In astrocyte cultures, release of D-serine is mediated by activation of AMPA receptors intrinsic to glial cells (20) . Thus D-serine regulation of NMDARs has opened up a new modality for glial participation in the control of neuronal excitability. A recent study, however, has raised the possibility that serine racemase and D-serine may also be found in neurons, so the idea of an exclusive role for D-serine as a mediator for glial-neuronal control has become more clouded (8) .
As a component of the central nervous system, the vertebrate retina has been a focus of pioneering studies of glial function and glial-neuronal interactions (21) . In the retina, NMDARs are found on ganglion cells, the output cells of the retina, and some amacrine cells (6; 18) . (30) and Müller cells (1) . In addition, the retina is a site in which glycine plays a prominent role as an inhibitory neurotransmitter released by a subset of amacrine cells (12; 17) .
Thus glycine may be comparatively high in the inner retina--the very region where NMDARs are located.
Complications related to previous work in the retina have come from recent studies related to the actions of DAAO. The enzyme is not selective for D-serine. It is more metabolically active against D-alanine and more importantly has been reported to deplete glycine levels (5). In addition, many commercially available DAAO preparations have been found to contain some level of D-aspartase activity, which may lead to the degradation of NMDA when it is used as an exogenous coagonist for NMDARs (27) . Thus, a previous study in the retina, in which DAAO was used to demonstrate reduced sensitivity to exogenously applied NMDA, could have an alternative explanation (31) due to possible contamination in the enzyme preparation with D-aspartase activity. In this study, we have addressed the limitations of prior work based Page 4 of 35 4 on DAAO by carrying out experiments using a more selective D-serine degrading enzyme, DsdA. Additionally, we have characterized the selectivity of both DsdA and DAAO against glycine and D-serine using capillary electrophoresis to measure the specificity of action of both enzymes.
We report that light-evoked responses in the retina are attenuated following the application of either of two different D-serine degrading enzymes-including, for the first time, the successful use of the highly selective enzyme DsdA in an intact tissue preparation.
Furthermore, this enzymatically based attenuation of the light response of retinal ganglion cells is dependent on activation of NMDARs-since no change is seen when they are applied in the presence of the NMDAR antagonist AP7. These findings strongly support a role for endogenous D-serine as a coagonist of NMDAR contributions to light-evoked activity in the inner retina.
Our results also suggest that under the experimental conditions of this study D-serine is the dominant and favored coagonist of NMDA receptors.
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Materials and Methods
Electrophysiology: Tiger salamanders (Ambystoma tigrinum) were purchased from a dealer (Charles D. Sullivan Co., Nashville, TN) and maintained in circulated cold-water tanks (4°C) with a 12 hour room light/dark cycle. Animal maintenance and experimental protocols were approved by the Institutional Animal Care and Use Committee at the University of Minnesota.
Animals were killed by decapitation followed by double pithing.
PNR experiments were performed in the amphibian eyecup preparation after removing the cornea and lens and draining the vitreous (16) . Beveled glass microelectrodes, with tip resistances of a few M , were filled with Ringer, mounted on a micromanipulator, inserted into the retina to a depth of 60-100 µm and adjusted to the maximum amplitude of the PNR (3).
Amplification was achieved by a Grass P16 amplifier connected to an A/D converter (DigiData 1200) and displayed using a computer controlled by PClamp software (9.0, Molecular Devices, Sunnyvale, CA), sampling at 1 kHz. A small spot of light (110 µm in diameter) from a 12V tungsten-iodide light source was positioned directly over the electrode. During recordings, focal light stimulation alternated with the presentation of a diffuse light stimulus that covered the entire retina. Stimulus intensity was controlled with neutral density filters. The eyecup was continually superfused, at a rate of 1-2 ml/min, with a cooled (19ºC), oxygenated, Mg 2+ -free Ringer solution. To maximize the NMDAR contribution to the PNR, a control cocktail solution containing (in µM) 10 NBQX (Tocris, Ellisville, NJ), 10 strychnine, 50 picrotoxinin, and 50 mecamylamine was applied. In these studies all additional pharmacological agents were added to this cocktail Ringer solution.
Whole cell recordings were obtained from identified ganglion cells in a flatmount retina preparation of the tiger salamander (31) . Isolated retinas were placed in a perfusion chamber, Ellisville, MO). Tissue D-serine degradation was carried out using 100 µg/ml of D-amino acid oxidase (Worthington, Lakewood, NJ) or 10 µg/ml of D-serine deaminase added to the perfusion 7 medium. Bacterial DsdA, which has been shown to be much more efficient in the removal of Dserine compared to DAAO, was isolated and purified by the methods previously outlined (27) .
Capillary Electrophoresis: Ringer samples containing 10 µM of both D-serine and glycine were incubated at room temperature with DAAO (100 µg/ml) or DsdA (10 µg/ml) in low volume (1.6 µL) centrifuge tubes for times ranging from one minute to four hours. Samples were then measured for their amino acid levels using a commercial capillary electrophoresis (CE) instrument with laser-induced fluorescence (LIF) detection (Beckman Coulter P/ACE MDQ), as previously described (23) . The samples were fluorescently derivatized at 60ºC for 15 minutes with 4-fluoro-7-nitrobenz-2-oxa-1,3-diazole (NBD-F, Molecular Probes, Eugene, OR) before being analyzed by CE using a hydroxypropyl-ß-cyclodextrin (HP-ß-CD) separation buffer. All data were collected and analyzed using Karat 32 software (Beckman Coulter, Fullerton, CA).
Statistics: CE and electrophysiological data were analyzed in Origin, 7.0 or 7.5 (Northhampton, MA). All results are expressed as the mean ± SEM and a student t-test was used to compare values; a p-value less than 0.05 was considered significant for all statistical analyses. Figure 1B shows the cumulative data from six experiments and illustrates that the ON response peak amplitude was reduced by 21.8 ± 4.6% of the control. The total charge, determined by integrating the response, was 25.0 ± 7.8% less than control. The OFF responses were also reduced with a peak amplitude reduction of 21.8 ± 4.2 % and a reduction in total charge to 28.1 ± 8.4% of control values (n= 6).
Results
Light
The enzymatic reductions for ON and OFF responses were significant when compared to control levels (p < 0.05).
We carried out a series of additional experiments to evaluate the actions of the more selective enzyme DsdA (Fig 1C,D) . DsdA attenuated both the ON and OFF responses of retinal ganglion cells. The peak amplitude of the ON response declined by 33.0 ± 10.0% while the total charge was reduced by 28.8 ± 5.9%. The peak amplitude of the OFF response was reduced by 24.8 ± 5.6% and the total charge was diminished by 32.0 ± 7.1% (n = 6, p < 0.05). In these experiments, we also determined whether the addition of exogenous D-serine to the enzyme bathing solution could restore the responses to control levels ( Fig 1D) . These observations illustrated that, in many cases, the addition of D-serine in the presence of the enzyme increased response amplitudes to levels higher than that of the controls. Heat inactivation of the enzymes, by exposing the enzyme solutions to a boiling water bath for 5 minutes, eliminated the suppressive effects of DAAO and DsdA on the light-evoked currents (not illustrated).
D-serine degradation attenuates extracellularly recorded NMDAR currents
Beveled glass microelectrodes were used to measure the Proximal Negative Response (PNR) in the tiger salamander eyecup. The PNR is a response of the inner retina that reflects activity of third-order retinal neurons, including amacrine and ganglion cells (3) . In standard, Mg 2+ -free Ringer, the NMDAR component of the PNR was minimal. Under these conditions, 9 blocking NMDA receptors with the antagonist AP7 did not significantly reduce the PNR; a decrease of 2.0 ± 3.8% of the peak amplitude was observed under these conditions (n=7; Fig 2D, inset: standard+AP7 vs standard). But when a cocktail of antagonists was added to the bathing medium (picrotoxinin, strychnine, mecamylamine, and NBQX), the PNR was enhanced and the relative contribution from NMDARs was pronounced. The addition of the cocktail itself increased the PNR amplitude, as measured at the peak of the ON response (Fig 2D, light gray vs.
black trace) and converted it to a light response that was largely composed of NMDAR -mediated current. When AP7 (100 µM) was added to the cocktail, the ON response of the PNR was reduced by 82.6 ± 4.1% (n = 7, Fig 2D) . By using the cocktail as the control bathing solution,
we were able to examine an NMDAR-dominated light evoked response of the inner retina with the convenience of extracellular recordings, which provided a more stable recording environment.
We confirmed previous studies of the PNR (carried out using a slightly different cocktail)
by demonstrating that enzymatic degradation of D-serine, through the addition of exogenous DAAO (100 µg/ml), reduced the magnitude of the NMDAR-dominated PNR (Fig 2A) (31) . To establish that this result was due to the activity of the enzyme, the enzyme was exposed to a boiling water bath for five minutes prior to application, after which application to the retina was devoid of any detectable influence on the PNR amplitude (data not shown).
We studied the actions of DsdA (10 µg/ml) through bath application of the enzyme:
DsdA decreased the NMDAR-dominated PNR. Figure 2B shows the results from a D-serine degradation experiment. In the presence of the control cocktail a large PNR response was recorded (black trace). After the addition of DsdA to the Ringer, the PNR response decreased (lower gray trace). Both DAAO and DsdA reduced the PNR amplitude, with an average 
Confirmation of enzyme specificity
We explored the possibility that the suppressive effects of DAAO and DsdA on the NMDAR-mediated responses of the inner retina could be the result of an action of these enzymes on glycine rather than D-serine. A degradation of glycine by DAAO has been previously reported (5). This determination was essential, as any reduction in glycine by these enzymes would invalidate our conclusions about the role of D-serine vs glycine as an NMDAR coagonist in the retina. We addressed this problem by using capillary electrophoresis (CE) to examine both the time course and specificity of action of the two enzymes on D-serine and glycine. When (Fig 3B) . Although the effects on Dserine versus glycine were similar with the two enzymes, DsdA was more efficient and powerful in its action on D-serine. DsdA led to the complete elimination of the D-serine peak in the electropherogram at the shortest incubation time without significantly affecting the glycine peak (Fig. 3A, B right) . In contrast, an identical study with DAAO revealed a much slower, timedependent drop in D-serine levels, but with no significant influence on glycine (Fig. 3B left) .
Thus, these studies clearly support the idea that enzymatic reductions in NMDA receptor contributions reflect the action of these enzymes on endogenous D-serine rather than glycine.
PNR amplitude is increased following application of exogenous D-serine
We used the enhanced PNR as a tool for evaluating the level of saturation of the NMDAR coagonist site under our experimental conditions. Figure 4A washout was sufficient to record a return to the control response ( Fig. 4B ; n = 6, p < 0.05).
Interestingly, response enhancement was also observed after some applications of D-serine added to DAAO or DsdA, enhancing the amplitude beyond the original values of the control s (see figure 2B ).
Manipulation of D-serine levels has no effect when NMDARs are blocked
Whole-cell recordings from retinal ganglion cells were used to examine the dependence of endogenous D-serine ma nipulation s on NMDAR activity. Fig 5A illustrates an example of Figure 5C illustrates the alternative experiment, in which a control light-evoked response was obtained from an On-Off ganglion cell in a Mg 2+ -free Ringer, after which the addition of AP7 reduced the light response and also had a significant effect in reducing the background inward current (or elevation of an outward current) accounting for the response displacement. Superimposed on the AP7 recording is a recording from the same cell obtained after adding 100 µM D-serine to the AP7 bathing solution. Because the two traces virtually superimpose, it is clear that the normally enhancing actions of D-serine on light-evoked currents of ganglion cells require the presence of functional NMDARs. Figure   5D summarizes the five experiments carried out identically to that illustrated in 5C. In analyzing and comparing the two by-products of D-serine degradation by DAAO (3-hydroxypyruvate) and DsdA (pyruvate). Using this method, the brains of rats and chickens were compared for D-serine metabolites. D-serine degradation in bird brains could be attributed to the actions of both DAAO and DsdA, but in the rat brain D-serine was metabolically restricted to DAAO. However, while it appears that DsdA is an unlikely player in mammalian nervous tissue, it has not to our knowledge been evaluated been evaluated with this more direct, functional technique in amphibians.
In addition to the link between endogenous D-serine and light-evoked NMDAR activation established in this study, we have addressed several major issues that have clouded our understanding about the role of D-Serine in the retina. The current study has established that, at physiological pH conditions, the enzymatic action of DAAO shows high selectivity for D-serine while having little effect on glycine levels. Thus, a previous report on DAAO degradation of glycine presumably reflected the high pH (10.3) used in that analysis (5) . In contrast, our study of DAAO selectivity was done using normal Ringer, at physiological pH (7.8) . Under these conditions we did not detect any glycine degradation even after several hours of exposure. We also established that when DAAO was applied to the retina, the associated decrease in NMDAR- observed effects on glycine, we conclude that endogenous D-serine plays a major role as an NMDAR coagonist in the salamander retina. While it is important to emphasize that our results do not eliminate the possibility that glycine also serves a companion NMDAR coagonist role, we were unable to find a significant level of residual NMDAR function that was not eliminated through the enzymatic exposures used in this study. Therefore, if glycine plays a significant role as an NMDAR coagonist in the retina, it must be operational under different experimental circumstances than those used in this study. Indeed, we believe that the results of this study have reversed the burden of proof for identifying the endogenous NMDAR coagonist in the retina, by replacing a presumed coagonist, glycine, with D-serine for which strong compelling evidence is now available. However, because of the multitude of different functional states in which the retina is designed to detect visual signals, it is premature to eliminate glycine from any functional role in setting NMDAR sensitivity. Nevertheless, our results provide a compelling case for Dserine as the major coagonist of NMDARs in the retina.
While we think it is unlikely that glycine plays a prominent role as an NMDAR coagonist in the retina, it occupies a place of prominence in retinal function and, for that reason alone, glycine merits some discussion. Glycine is a prominent, inhibitory amino acid in the retina, utilized by a subset of amacrine cells (12; 17) . It is widely assumed that, in the brain, glycine
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uptake through the GlyT1 transporters, which are localized to astrocytes, serves to regulate the availability of glycine and determines its role as a coagonist of NMDARs (2) . In contrast to the brain, the distribution of the GlyT1 transporters in the retina is more complex and may differ across species. In mammalian and chick retinas, it appears that GlyT1 transporters are absent in glia, but are found instead in a subset of glycinergic amacrine cells (25) where, surprisingly, the GlyT1 transporter plays a central role in glycine accumulation in these cells (24) , as very little net glycine synthesis is present. In contrast to the mammalian/chick retinas, recent studies in the bullfrog retina have presented evidence for GlyT1 transporters in Müller cells (7) (9).
In the brain, the co-distribution of NMDARs and GlyT1 transporters has been examined at the ultrastructural level (28) and revealed a close correspondence and apposition of these two membrane embedded proteins. This correspondence has raised speculation that the GlyT1 transporters play a special role in setting the background levels of glycine and hence in regulating NMDAR sensitivity. We suggest that a similar relationship may exist in the retina. DsDa action proves to be rapid, with no levels detected even with the shortest incubation times.
Glycine levels are not affected by either enzyme, even after four hours of incubation. (AP7) and 28.8 ± 5.9% (DsdA). For the OFF responses, the decrease from control was 42.6 ±
